BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche's New $152,850 Breast Cancer Drug     8/11/2014
Puma Biotechnology Shares Soar On Breast Cancer Drug Results     7/28/2014
Amgen, Bayer HealthCare's Nexavar Fails Late-Stage Breast Cancer Study     7/25/2014
Pfizer Inc. Backs Out of Funding Puma Biotechnology Cancer Drug Trials     7/24/2014
Celsion Corporation Announces Positive Interim Data Update From Its Phase 2 DIGNITY Study In Breast Cancer     7/24/2014
Pfizer Inc. Pursues Early Approval For Breast Cancer Drug     5/19/2014
Heat On Roche To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No"     4/23/2014
Stolen Roche Cancer Drug Found On Market     4/18/2014
Puma Biotechnology Plummets On Disappointing Breast Cancer Drug Results     4/9/2014
Pfizer Inc. Continues Its Streak, Phase 2 Breast Cancer Results Wows Investors And Researchers     4/8/2014
Curis, Inc. Announces Removal Of FDA Partial Clinical Hold On CUDC-427     3/31/2014
Roche Wins Battle Over Launch Of Biosimilar Version Of Its Breast Cancer Drug Herceptin     2/7/2014
Pfizer Inc.'s New Breast Cancer Treatment Succeeds In Phase 2 Trial     2/4/2014
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.), Astellas Pharma Inc. Discontinue Phase 2 Trial Of Tivozanib In Breast Cancer     1/30/2014
BioCon Limited Hits Roche First, Set To Launch Biosimilar Of Breast Cancer Drug Herceptin     1/21/2014
 Featured Stories
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals     8/7/2014
Birth Control Pills May Double Breast Cancer Risk, Fred Hutchinson Cancer Research Center Study     8/4/2014
Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study     7/28/2014
Association Found Between High Cholesterol And Breast Cancer, Aston University School Of Medical Sciences Study     7/7/2014
No Link Found Between Fertility Drugs And Cancers, University of Illinois Study     7/1/2014
Harmless Virus Kills Cancer And Tumor Cells, Pennsylvania State University Study     6/26/2014
Single Drug Could Soon Cure High Cholesterol, Breast Cancer, University of Missouri Study     6/19/2014
Red Meat Possibly Linked To Breast Cancer, Harvard School of Public Health Study     6/12/2014
Moles Linked To Breast Cancer Risk, Indiana University And Harvard University Study     6/11/2014
Can Mice Mimic Human Breast Cancer? Michigan State University Study Says "Yes"     6/6/2014
Antimicrobial Ingredient In Health Products Spurs Growth Of Breast Cancer Cells, American Chemical Society Reveals     4/25/2014
High-Fat Diets Linked To CertainTypes Of Breast Cancer, Fondazione IRCCS National Cancer Institute Study     4/23/2014
Body Mass Index, Not Body Shape Ups Breast Cancer Risk, American Cancer Society Reveals     4/21/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Can Vitamin A Turn Back The Clock On Breast Cancer? Thomas Jefferson University Study     3/31/2014
 More News
Research Study At Banner MD MD Anderson Cancer Center Tests New Drug To Fight BRCA-Associated Breast Cancer     8/20/2014
Pfizer Inc. (PFE) Announces Submission Of Palbociclib New Drug Application To The FDA     8/18/2014
Merrimack Pharmaceuticals Inc. (MACK) Announces Initiation Of HERMIONE, A Randomized Trial Of MM-302 In Patients With Advanced HER2-Positive Breast Cancer To Support Application For Accelerated Approval     8/11/2014
Susan G. Komen for the Cure And Northern Arizona (Komen CAN AZ) Selects And Retains Ideas Collide To Combat Breast Cancer     8/1/2014
CASI Pharmaceuticals  (ENMD) Receives Approval From CFDA To Conduct Phase 2 Clinical Trial With Enmd-2076 For Triple-Negative Breast Cancer In China     7/21/2014
RedHill Biopharma Ltd. (RDHL) Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG (WL6.DE)     6/30/2014
AbbVie (ABBV) Announces Initiation Of Pivotal Phase 3 Study Of Veliparib (ABT-888) In Patients With Advanced Breast Cancer     6/26/2014
FDA Approves Bayer HealthCare (BAY)'s Gadavist (Gadobutrol) Injection As The First Magnetic Resonance Contrast Agent For Evaluation Of Breast Cancer In The United States     6/12/2014
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial     6/12/2014
Caris Life Sciences Research Provides Key Clinical Insights On Immunotherapeutic Targets In A Broad Range Of Cancers     6/10/2014
Caris Life Sciences Biomarker Research Suggests Role For Immune-Targeted Therapies In Subsets Of Patients With Triple Negative Breast Cancer (TNBC)     6/3/2014
GTx, Inc. (GTXI) Reports Positive Clinical Data From Open Label Phase 2 Study Of Enobosarm In Patients With Androgen And Estrogen Receptor Positive Metastatic Breast Cancer     6/2/2014
Eisai Company, Ltd. (ESALY.PK) Receives Positive Opinion From European Medicines Agency's CHMP On Expanding     5/27/2014
Depymed Announces Validation Of Trodusquemine As A Therapeutic Candidate For HER2-Positive Breast Cancer     5/27/2014
GTx, Inc. (GTXI) To Present Clinical Data On Enobosarm In Breast Cancer And NSCLC At B. Allen Group 2014 Annual Meeting     5/19/2014